Genome-wide mapping of RELA(p65) binding identifies E2F1 as a transcriptional activator recruited by NF-kappaB upon TLR4 activation.

NF-kappaB is a key mediator of inflammation. Here, we mapped the genome-wide loci bound by the RELA subunit of NF-kappaB in lipopolysaccharide (LPS)-stimulated human monocytic cells, and together with global gene expression profiling, found an overrepresentation of the E2F1-binding motif among RELA-bound loci associated with NF-kappaB target genes. Knockdown of endogenous E2F1 impaired the LPS inducibility of the proinflammatory cytokines CCL3(MIP-1alpha), IL23A(p19), TNF-alpha, and IL1-beta. Upon LPS stimulation, E2F1 is rapidly recruited to the promoters of these genes along with p50/RELA heterodimer via a mechanism that is dependent on NF-kappaB activation. Together with the observation that E2F1 physically interacts with p50/RELA in LPS-stimulated cells, our findings suggest that NF-kappaB recruits E2F1 to fully activate the transcription of NF-kappaB target genes. Global gene expression profiling subsequently revealed a spectrum of NF-kappaB target genes that are positively regulated by E2F1, further demonstrating the critical role of E2F1 in the Toll-like receptor 4 pathway.

[1]  Kevin Struhl,et al.  Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells. , 2006, Molecular cell.

[2]  T. Lawrence,et al.  Anti-inflammatory lipid mediators and insights into the resolution of inflammation , 2002, Nature Reviews Immunology.

[3]  J. Boss,et al.  Role of the Intronic Enhancer in Tumor Necrosis Factor-mediated Induction of Manganous Superoxide Dismutase* , 2003, Journal of Biological Chemistry.

[4]  D. Galloway,et al.  Mechanisms by which DNA tumor virus oncoproteins target the Rb family of pocket proteins. , 2003, Carcinogenesis.

[5]  X. Chen,et al.  The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells , 2006, Nature Genetics.

[6]  J. Nevins,et al.  Expression of transcription factor E2F1 induces quiescent cells to enter S phase , 1993, Nature.

[7]  C. Jefferies,et al.  Interferon Regulatory Factor-3-mediated Activation of the Interferon-sensitive Response Element by Toll-like receptor (TLR) 4 but Not TLR3 Requires the p65 Subunit of NF-κ* , 2003, Journal of Biological Chemistry.

[8]  T. Torgerson,et al.  Inhibition of Nuclear Translocation of Transcription Factor NF-κB by a Synthetic Peptide Containing a Cell Membrane-permeable Motif and Nuclear Localization Sequence (*) , 1995, The Journal of Biological Chemistry.

[9]  D. Cook.  The role of MIP‐1α in Inflammation and hematopoiesis , 1996, Journal of leukocyte biology.

[10]  Thomas E. Royce,et al.  Distribution of NF-κB-binding sites across human chromosome 22 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. Shih,et al.  The VEGF-C/Flt-4 axis promotes invasion and metastasis of cancer cells. , 2006, Cancer cell.

[12]  Mark Bieda,et al.  Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome. , 2006, Genome research.

[13]  Gioacchino Natoli,et al.  Interactions of NF-κB with chromatin: the art of being at the right place at the right time , 2005, Nature Immunology.

[14]  H. Pahl.  Activators and target genes of Rel/NF-κB transcription factors , 1999, Oncogene.

[15]  M J May,et al.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. , 1998, Annual review of immunology.

[16]  M. Tomonaga,et al.  Bay 11-7082 inhibits transcription factor NF-kappaB and induces apoptosis of HTLV-I-infected T-cell lines and primary adult T-cell leukemia cells. , 2002, Blood.

[17]  C. Rosen,et al.  NF-kappa B subunit-specific regulation of the interleukin-8 promoter , 1993, Molecular and cellular biology.

[18]  C. Dinarello,et al.  The IL-1 family and inflammatory diseases. , 2002, Clinical and experimental rheumatology.

[19]  Richard G. Jenner,et al.  Coordinated binding of NF-kappaB family members in the response of human cells to lipopolysaccharide. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[20]  Graziano Pesole,et al.  An algorithm for finding signals of unknown length in DNA sequences , 2001, ISMB.

[21]  C. Harris,et al.  Chronic inflammation promotes retinoblastoma protein hyperphosphorylation and E2F1 activation. , 2005, Cancer research.

[22]  B. Aggarwal.  Signalling pathways of the TNF superfamily: a double-edged sword , 2003, Nature Reviews Immunology.

[23]  M. Katerelos,et al.  Inhibition of NF-κB activation by a dominant-negative mutant of IκBα , 1996 .

[24]  Hongyu Zhao,et al.  Inactivating E2f1 reverts apoptosis resistance and cancer sensitivity in Trp53-deficient mice , 2003, Nature Cell Biology.

[25]  R. Weinberg,et al.  TGF beta-induced growth inhibition in primary fibroblasts requires the retinoblastoma protein. , 1996, Molecular biology of the cell.

[26]  Z. Weng,et al.  A Global Map of p53 Transcription-Factor Binding Sites in the Human Genome , 2006, Cell.

[27]  B. Beutler,et al.  Identification of a TLR4‐ and TRIF‐dependent activation program of dendritic cells , 2004, European journal of immunology.

[28]  S. Cawley,et al.  Unbiased Mapping of Transcription Factor Binding Sites along Human Chromosomes 21 and 22 Points to Widespread Regulation of Noncoding RNAs , 2004, Cell.

[29]  M. Karin,et al.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. , 2000, Annual review of immunology.

[30]  K. Helin,et al.  The E2F family: specific functions and overlapping interests , 2004, The EMBO journal.

[31]  B. Beutler,et al.  Inferences, questions and possibilities in Toll-like receptor signalling , 2004, Nature.

[32]  S. Batalov,et al.  A Strategy for Probing the Function of Noncoding RNAs Finds a Repressor of NFAT , 2005, Science.

[33]  A. Sher,et al.  IL-23 plays a key role in Helicobacter hepaticus–induced T cell–dependent colitis , 2006, The Journal of experimental medicine.

[34]  A. Hoffmann,et al.  Molecular Determinants of Crosstalk between Nuclear Receptors and Toll-like Receptors , 2005, Cell.

[35]  Neil J McKenna,et al.  A Steroid Receptor Coactivator, SRA, Functions as an RNA and Is Present in an SRC-1 Complex , 1999, Cell.

[36]  A. Hoffmann,et al.  Selective requirement for c-Rel during IL-12 P40 gene induction in macrophages. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[37]  A. Saïb,et al.  A Cellular MicroRNA Mediates Antiviral Defense in Human Cells , 2005, Science.

[38]  A. Thiel,et al.  The IκB Kinase Complex and NF-κB Actas Master Regulators of Lipopolysaccharide-Induced Gene Expressionand Control Subordinate Activation ofAP-1 , 2004, Molecular and Cellular Biology.

[39]  D. Baltimore,et al.  NF-κB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses , 2006, Proceedings of the National Academy of Sciences.

[40]  S. Smale,et al.  Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: evidence of functional synergy between C/EBP and Rel proteins , 1997, Molecular and cellular biology.

[41]  R. Roeder,et al.  Interaction between Cell Cycle Regulator, E2F-1, and NF-κB Mediates Repression of HIV-1 Gene Transcription* , 1997, The Journal of Biological Chemistry.

[42]  T. Mcclanahan,et al.  IL-23 promotes tumour incidence and growth , 2006, Nature.

[43]  Alexander E. Kel,et al.  TRANSFAC®: transcriptional regulation, from patterns to profiles , 2003, Nucleic Acids Res..

[44]  C. Albanese,et al.  E2F1 and c-Myc potentiate apoptosis through inhibition of NF-kappaB activity that facilitates MnSOD-mediated ROS elimination. , 2002, Molecular cell.

[45]  N. Perkins,et al.  Active Repression of Antiapoptotic Gene Expression by RelA(p65) NF-κB , 2004 .

[46]  P. Igaz,et al.  Biological and clinical significance of the JAK-STAT pathway; lessons from knockout mice , 2001, Inflammation Research.